133 related articles for article (PubMed ID: 24402303)
21. Clinical significance of expression and epigenetic profiling of TUSC1 in gastric cancer.
Kanda M; Shimizu D; Nomoto S; Hibino S; Oya H; Takami H; Kobayashi D; Yamada S; Inokawa Y; Tanaka C; Fujii T; Sugimoto H; Koike M; Fujiwara M; Kodera Y
J Surg Oncol; 2014 Aug; 110(2):136-44. PubMed ID: 24700496
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B.
Tomizawa Y; Sekido Y; Kondo M; Gao B; Yokota J; Roche J; Drabkin H; Lerman MI; Gazdar AF; Minna JD
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13954-9. PubMed ID: 11717452
[TBL] [Abstract][Full Text] [Related]
24. Association of NDRG1 gene promoter methylation with reduced NDRG1 expression in gastric cancer cells and tissue specimens.
Chang X; Zhang S; Ma J; Li Z; Zhi Y; Chen J; Lu Y; Dai D
Cell Biochem Biophys; 2013 May; 66(1):93-101. PubMed ID: 23099645
[TBL] [Abstract][Full Text] [Related]
25. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T
Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832
[TBL] [Abstract][Full Text] [Related]
26. Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers.
Loginov VI; Dmitriev AA; Senchenko VN; Pronina IV; Khodyrev DS; Kudryavtseva AV; Krasnov GS; Gerashchenko GV; Chashchina LI; Kazubskaya TP; Kondratieva TT; Lerman MI; Angeloni D; Braga EA; Kashuba VI
PLoS One; 2015; 10(5):e0123369. PubMed ID: 25961819
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.
Kim M; Lee KT; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Kim SY; Yoo HS; Kim YS
Mol Cancer Res; 2008 Feb; 6(2):222-30. PubMed ID: 18314483
[TBL] [Abstract][Full Text] [Related]
28. Methylation-associated silencing of miR-495 inhibit the migration and invasion of human gastric cancer cells by directly targeting PRL-3.
Li Z; Zhang G; Li D; Jie Z; Chen H; Xiong J; Liu Y; Cao Y; Jiang M; Le Z; Tan S
Biochem Biophys Res Commun; 2015 Jan; 456(1):344-50. PubMed ID: 25475733
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of SEMA3B gene silencing and clinical significance in glioma.
Pang CH; Du W; Long J; Song LJ
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050958
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of A disintegrin and metallopeptidase with thrombospondin motif type 1 by DNA hypermethylation in human gastric cancer.
Chen J; Zhang C; Xu X; Zhu X; Dai D
Mol Med Rep; 2015 Aug; 12(2):2487-94. PubMed ID: 25936341
[TBL] [Abstract][Full Text] [Related]
32. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
Takada H; Imoto I; Tsuda H; Nakanishi Y; Ichikura T; Mochizuki H; Mitsufuji S; Hosoda F; Hirohashi S; Ohki M; Inazawa J
Oncogene; 2005 Dec; 24(54):8051-60. PubMed ID: 16103878
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer.
Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H
Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515
[TBL] [Abstract][Full Text] [Related]
34. [Mutation and expression of SEMA3B and SEMA3F gene in nasopharyngeal carcinoma].
Liu XQ; Sun M; Chen HK; Li JX; Pan ZG; Long QX; Wang XZ; Zeng YX
Ai Zheng; 2003 Jan; 22(1):16-20. PubMed ID: 12561429
[TBL] [Abstract][Full Text] [Related]
35. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.
Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F
Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation.
Ling Y; Shi X; Wang Y; Ling X; Li Q
Biochem Biophys Res Commun; 2014 Feb; 444(2):147-52. PubMed ID: 24434154
[TBL] [Abstract][Full Text] [Related]
38. Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer.
Lin YL; Chen HL; Cheng SB; Yeh DC; Huang CC; P'eng FK; Tsai TC; Wu CC; Chen CM
Int J Clin Exp Pathol; 2015; 8(11):14257-69. PubMed ID: 26823742
[TBL] [Abstract][Full Text] [Related]
39. Placental SEMA3B expression is not altered in severe early onset preeclampsia.
Kaitu'u-Lino TJ; Hastie R; Cannon P; Binder NK; Lee S; Stock O; Hannan NJ; Tong S
Placenta; 2014 Dec; 35(12):1102-5. PubMed ID: 25454475
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion.
Kim M; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Norman JC; Caswell PT; Kang GH; Kim SY; Yoo HS; Kim YS
Carcinogenesis; 2008 Mar; 29(3):629-37. PubMed ID: 18283041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
